Medtronic (NYSE:MDT) Upgraded to Strong-Buy at Leerink Partnrs
Leerink Partnrs upgraded shares of Medtronic (NYSE:MDT – Free Report) to a strong-buy rating in a research report sent to investors on Monday morning,Zacks.com reports. Leerink Partnrs also issued estimates for Medtronic’s Q1 2026 earnings at $1.23 EPS, Q2 2026 earnings at $1.32 EPS, Q3 2026 earnings at $1.38 EPS, Q4 2026 earnings at $1.62 […]
